<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Insights into <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> genetics can lead to therapeutic opportunities </plain></SENT>
<SENT sid="1" pm="."><plain>By cross-referencing chromosomal changes with an unbiased genetic screen we identify the ephrin receptor A7 (EPHA7) as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor in follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) </plain></SENT>
<SENT sid="2" pm="."><plain>EPHA7 is a target of 6q deletions and inactivated in 72% of FLs </plain></SENT>
<SENT sid="3" pm="."><plain>Knockdown of EPHA7 drives <z:hpo ids='HP_0002665'>lymphoma</z:hpo> development in a murine FL model </plain></SENT>
<SENT sid="4" pm="."><plain>In analogy to its physiological function in brain development, a soluble splice variant of EPHA7 (EPHA7(TR)) interferes with another Eph-receptor and blocks oncogenic signals in <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells </plain></SENT>
<SENT sid="5" pm="."><plain>Consistent with this drug-like activity, administration of the purified EPHA7(TR) protein produces antitumor effects against xenografted human <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Further, by fusing EPHA7(TR) to the anti-CD20 antibody (rituximab) we can directly target this <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor to <z:hpo ids='HP_0002665'>lymphomas</z:hpo> in vivo </plain></SENT>
<SENT sid="7" pm="."><plain>Our study attests to the power of combining descriptive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> genomics with functional screens and reveals EPHA7(TR) as <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor with immediate therapeutic potential </plain></SENT>
</text></document>